Showing results (2591-2600 of 2,696) with videos related to
Sort By:
Pageof 270
The Lancet. Infectious Diseases|February 27, 2015
β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options?Patrick N A Harris, Paul A Tambyah, David L PatersonThe Lancet. Infectious Diseases|July 17, 2020
Evolving viral and serological stages of Zika virus RNA-positive blood donors and estimation of incidence of infection during the 2016 Puerto Rican Zika epidemic: an observational cohort studyPhillip C Williamson, Brad J Biggerstaff, Graham Simmons, et al.The Lancet. Infectious Diseases|January 26, 2015
The expanding role of co-trimoxazole in developing countriesJames A Church, Felicity Fitzgerald, A Sarah Walker, et al.The Lancet. Infectious Diseases|January 27, 2015
Chains of transmission and control of Ebola virus disease in Conakry, Guinea, in 2014: an observational studyOusmane Faye, Pierre-Yves Boëlle, Emmanuel Heleze, et al.The Lancet. Infectious Diseases|August 22, 2025
Efficacies of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in children aged 6 months to 10 years in Uganda: a randomised, open-label, phase 4 clinical trialMoses R Kamya, Joaniter I Nankabirwa, Chris Ebong, et al.The Lancet. Infectious Diseases|March 13, 2023
Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort studyHiam Chemaitelly, Houssein H Ayoub, Patrick Tang, et al.The Lancet. Infectious Diseases|March 16, 2023
Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort studyCeline Y Tan, Calvin J Chiew, Deanette Pang, et al.The Lancet. Infectious Diseases|March 26, 2023
Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trialGail B Cross, Intan P Sari, Cissy Kityo, et al.The Lancet. Infectious Diseases|July 1, 2015
CorrectionsThe Lancet. Infectious Diseases|May 26, 2015
Spatial distribution of schistosomiasis and treatment needs in sub-Saharan Africa: a systematic review and geostatistical analysisYing-Si Lai, Patricia Biedermann, Uwem F Ekpo, et al.Pageof 270